- Home
- Labeler Index
- Loxo Oncology, Inc.
- 71777-390
- NDC Crossover: 71777-390 Vitrakvi
NDC Crossover 71777-390 Vitrakvi
View and Compare Similar Products, Alternatives & Options
NDC Crossover of Similar Products Matching Larotrectinib
The Similar Products in this help users find alternative medications and related products based on key similarities in their regulatory status, product name, active ingredients, dosage form, and administration route.
Explore similar products to 71777-390 – Vitrakvi, a human prescription drug. This list includes other cross-matching products that share:
- The same product name: Vitrakvi
- OR Generic name: Larotrectinib
- AND the same Administration Route: oral
- OR Dosage Form: capsule
| NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Company Name | Product Type |
|---|---|---|---|---|---|---|
| 50419-390 | Vitrakvi | Larotrectinib | Capsule | Oral | Bayer Healthcare Pharmaceuticals Inc. | Human Prescription Drug |
| 50419-391 | Vitrakvi | Larotrectinib | Capsule | Oral | Bayer Healthcare Pharmaceuticals Inc. | Human Prescription Drug |
| 71777-391 | Vitrakvi | Larotrectinib | Capsule | Oral | Loxo Oncology, Inc. | Human Prescription Drug |
| 71777-392 | Vitrakvi | Larotrectinib | Solution | Oral | Loxo Oncology, Inc. | Human Prescription Drug |
